SI-BONE, Inc.

Clinical trials sponsored by SI-BONE, Inc., explained in plain language.

SI-BONE, Inc. SIBN NASDAQ

Medical device company specializing in minimally invasive sacroiliac joint fusion.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 3

New pelvic implant aims to help seniors heal faster

Disease control Recruiting now

This study will follow 120 adults aged 60 and older who have a pelvic fracture and are scheduled to receive the iFuse TORQ TNT implant, a screw-like device that stabilizes the pelvis. Researchers will check if the device stays in place, doesn't break, and doesn't require addition…

Sponsor: SI-BONE, Inc. • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

SI-BONE, Inc.

New pelvic implant aims to help seniors heal faster